| Financial Year |
March 31 2023 |
| Monetary Funds |
5,242,568,732.75 |
| Held-for-trading Financial Assets |
68,914,358.37 |
| Notes Receivable |
-- |
| Accounts Receivable |
808,268,169.32 |
| Advances to Suppliers |
83,199,450.77 |
| Other Receivables |
756,377,975.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
27,038,963.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
68,951,848.88 |
| Total Current Assets |
7,067,108,299.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
776,573,593.38 |
| Investment Properties |
33,987,875.64 |
| Fixed Assetes |
236,944,520.66 |
| Under-construction Projects |
1,237,873,585.61 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
4,677,646,763.81 |
| Intangible Assets |
35,603,756.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,050,588.60 |
| Deferred Income Tax Assets |
9,995,875.97 |
| Other Non-Current Assets |
593,861,562.90 |
| Sub-Total of Non-Current Assets |
7,891,977,370.10 |
| Total Assets |
14,959,085,670.01 |
| Short-Term Loans |
458,878,354.87 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,109,543,406.85 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,711,498.68 |
| Taxes Payable |
195,812,498.02 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
101,956,133.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,026,709,685.46 |
| Other Current Liabilities |
5,133,269.78 |
| Sub-Total of Current Liabilities |
3,034,023,738.23 |
| Long-term Loans |
2,127,570,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
28,097,528.97 |
| Special Payable |
-- |
| Estimatied Liabilities |
223,227,751.60 |
| Deferred Income Tax Liabilities |
332,375,253.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,759,704,220.04 |
| Total Liabilities |
5,793,727,958.27 |
| Paid-In Capital(Or Share Stock) |
423,921,327.00 |
| Capital Surplus |
2,120,436,643.35 |
| Surplus Reserve |
188,497,569.93 |
| LESS:Treasury Stock |
27,048,755.36 |
| Undistributed Profits |
2,698,570,151.39 |
| Minority Stockholder's Interest |
3,808,379,265.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,356,978,446.46 |
| Owner's Equity（Stockholder's Equity） |
9,165,357,711.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,959,085,670.01 |
